Novartis AG
1,4-DISUBSTITUTED PYRIDAZINE ANALOGS THERE OF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS
Last updated:
Abstract:
The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; ##STR00001## a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Status:
Application
Type:
Utility
Filling date:
2 Jan 2019
Issue date:
28 Nov 2019